Malignant diseases Elderly patients over 70 years C00-C97
Conditions
Interventions
Group 1: Participating patients undergo an assessment before start of therapy consisting of the application of an oncogeriatric score (CARG score) and a medication review. Depending on the result, an
Sponsors
Pharmazeutisches Institut
Eligibility
Sex/Gender
All
Age
70 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Inpatient at Johanniter-Hospital Bonn 2. Age = 70 years 3. Diagnosis of any malignancy 4. Systemic drug treatment consisting of at least one chemotherapeutic drug 5. Written informed consent 6. Sufficient knowledge of German
Exclusion criteria
Exclusion criteria: 1. Cognitive impairment preventing the understanding of the purpose or procedures of the study 2. Previous systemic cancer treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility and acceptance of an interprofessional, risk-adapted medication management | — |
Secondary
| Measure | Time frame |
|---|---|
| Toxicity (CTCAE criteria), Symptom burden (PRO-CTCAE criteria), Health-related quality of life (EQ-5D-5L), Therapy changes, each assessed once per cycle | — |
Countries
Germany
Contacts
Public ContactJulia Thevissen
Pharmazeutisches Institut
Outcome results
None listed